Orient EuroPharma Co., Ltd.

Founded in 1982, Orient EuroPharma (OEP) became officially listed in the Taiwan Exchange in 2003. In the beginning, the Company was a prescription drug distributor, but has now become a full-scale, multinational pharmaceutical company. The core competencies of the Company not only include pharmaceutical innovation, R&D, manufacturing, sales and clinical trials, but has significantly increased the Company's operational efficiency through vertical integration to provide customers with more complete services. In 2002, the consolidated revenue exceeded NTD 4.7 billion and the Company has nearly 1,000 employees worldwide, of which about 40% are overseas personnel.

Regardless of OEP headquarters, pharmaceutical factories, R&D centers or overseas subsidiaries, the dedication of the Company's supervisors and employees is evident. In an atmosphere that highly regards communication, not only are professionalism and data important, but respect towards people is greatly valued so that the condition and voices of its partners are always important. At work, the Company’s core value - Through Integrity, united we achieve and be remarkable, is manifested in every detail of the team effort to innovate and grow together.